XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statement of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash Flows From Operating Activities    
Net Income (Loss) $ 6,939 $ 7,950
Adjustments to reconcile net income (loss) to net cash provided by operating activities    
Depreciation, depletion and amortization 6,935 6,047
Impairments 34 12
Dry hole costs and leasehold impairments 48 151
Accretion on discounted liabilities 240 204
Deferred taxes 249 753
Distributions more (less) than income from equity affiliates 545 920
(Gain) loss on dispositions (86) (200)
Other (18) 16
Working capital adjustments    
Decrease (increase) in accounts and notes receivable 656 1,147
Decrease (increase) in inventories (100) (114)
Decrease (increase) in prepaid expenses and other current assets (53) 486
Increase (decrease) in accounts payable (117) (837)
Increase (decrease) in taxes and other accruals 395 (1,833)
Net Cash Provided by Operating Activities 15,667 14,702
Cash Flows From Investing Activities    
Capital expenditures and investments (8,801) (8,365)
Working capital changes associated with investing activities 195 (175)
Acquisition of businesses, net of cash acquired 49 0
Proceeds from asset dispositions 217 613
Net sales (purchases) of investments (599) 1,860
Other (11) (81)
Net Cash Used in Investing Activities (8,950) (6,148)
Cash Flows From Financing Activities    
Issuance of debt 0 3,787
Repayment of debt (607) (1,243)
Issuance of company common stock (66) (57)
Repurchase of company common stock (3,513) (4,300)
Dividends paid (2,749) (4,175)
Other (131) (34)
Net Cash Used in Financing Activities (7,066) (6,022)
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash (28) (150)
Net Change in Cash, Cash Equivalents and Restricted Cash (377) 2,382
Cash, cash equivalents and restricted cash at beginning of period [1] 5,899 6,694
Cash, Cash Equivalents and Restricted Cash at End of Period [1] $ 5,522 $ 9,076
[1]
Restricted cash of $301 million and $264 million is included in the "Other assets" line of our Consolidated Balance Sheet as of September 30, 2024 and December 31, 2023, respectively.